| HOME >> BIOLOGY >> TECHNOLOGY |
The following non-cash items that were reflected in non-operating income and expense for the periods ended September 30, 2007 and 2006 are excluded from proforma net loss:
-- "Mark-to-market" adjustments to the 3% Senior Secured Convertible Note
and the 0% Convertible Senior Unsecured Debt. Favorable adjustments
of $4.2 million and $4.7 million were recorded in the three and nine
months ending September 30, 2007, respectively. There were no such
adjustments in the prior year, although a favorable adjustment of $2.2
million was recorded at January 1, 2007 for the cumulative effect of
the change in accounting principle at that date. Such adjustments
could be significant and unpredictable in future quarters depending on
several factors, including the level of the Company's common stock
price.
-- "Mark-to-market" adjustments in 2006 to the liability established for
the payment on the CVRs issued as part of the merger consideration for
ACLARA. As the outstanding CVR's were settled in the second quarter of
2006, adjustments are not significant for third and fourth quarters of
2006 or for 2007. An unfavorable adjustment of $16.5 million was
recorded in the nine months ended September 30, 2006.
Conference Call Details
Monogram will host a conference call today at 4:30 p.m. Eastern Time.
To participate in the live teleconference please call (877) 548-7912, or
(719) 325-4878 for international callers, fifteen minutes before the
conference begins. Live audio of the call will be simultaneously broadcast
over the Internet and will be available to members of the news media,
investors and the general public. Access to live and archived audio of the
conference call will be available by following the appropriate links at
http://www.monogramb
'/>"/>
| SOURCE Monogram Biosciences, Inc. Copyright©2007 PR Newswire. All rights reserved |